##gff-version 3
Q06547	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;Ontology_term=ECO:0007744;evidence=ECO:0007744|PubMed:22814378;Dbxref=PMID:22814378	
Q06547	UniProtKB	Chain	2	395	.	.	.	ID=PRO_0000066993;Note=GA-binding protein subunit beta-1	
Q06547	UniProtKB	Repeat	5	34	.	.	.	Note=ANK 1	
Q06547	UniProtKB	Repeat	37	66	.	.	.	Note=ANK 2	
Q06547	UniProtKB	Repeat	70	99	.	.	.	Note=ANK 3	
Q06547	UniProtKB	Repeat	103	132	.	.	.	Note=ANK 4	
Q06547	UniProtKB	Repeat	136	166	.	.	.	Note=ANK 5	
Q06547	UniProtKB	Region	258	327	.	.	.	Note=Transcription activation and HCFC1 interaction	
Q06547	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylserine;Ontology_term=ECO:0007744;evidence=ECO:0007744|PubMed:22814378;Dbxref=PMID:22814378	
Q06547	UniProtKB	Modified residue	69	69	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00420	
Q06547	UniProtKB	Modified residue	352	352	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00420	
Q06547	UniProtKB	Modified residue	381	381	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q00420	
Q06547	UniProtKB	Alternative sequence	195	206	.	.	.	ID=VSP_000275;Note=In isoform 2 and isoform 4. Missing;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:15489334,ECO:0000303|PubMed:7799916,ECO:0000303|PubMed:8441384;Dbxref=PMID:15489334,PMID:7799916,PMID:8441384	
Q06547	UniProtKB	Alternative sequence	346	395	.	.	.	ID=VSP_009337;Note=In isoform 3 and isoform 4. EREALQKQLDEANREAQKYRQQLLKKEQEAEAYRQKLEAMTRLQTNKEAV->VRSLLPGVLCRSHPK;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:15489334,ECO:0000303|PubMed:7799916,ECO:0000303|Ref.4;Dbxref=PMID:15489334,PMID:7799916	
Q06547	UniProtKB	Natural variant	31	31	.	.	.	ID=VAR_035613;Note=In a colorectal cancer sample%3B somatic mutation. P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=PMID:16959974	
Q06547	UniProtKB	Mutagenesis	262	263	.	.	.	Note=Minor reduction in transcriptional activation%3B when associated with A-295 or A-305 and A-306. QQ->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8816484;Dbxref=PMID:8816484	
Q06547	UniProtKB	Mutagenesis	264	265	.	.	.	Note=Minor effect upon interaction with HCFC1 and transcriptional activation. Loss of activity%3B when associated with A-297%3B A-298 and A-299%2C or with A-307 and A-310. VV->AA;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10675337,ECO:0000269|PubMed:8816484;Dbxref=PMID:10675337,PMID:8816484	
Q06547	UniProtKB	Mutagenesis	270	271	.	.	.	Note=Minor reduction in transcriptional activation. Moderate reduction in activity%3B when associated with A-305 and A-306. QQ->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8816484;Dbxref=PMID:8816484	
Q06547	UniProtKB	Mutagenesis	273	275	.	.	.	Note=Strongly reduces interaction with HCFC1 and transcriptional activation. Loss of activity%3B when associated with A-297%3B A-298 and A-299%2C or with A-307 and A-310. ITI->ATA;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10675337,ECO:0000269|PubMed:8816484;Dbxref=PMID:10675337,PMID:8816484	
Q06547	UniProtKB	Mutagenesis	295	295	.	.	.	Note=No effect on transcriptional activation. Minor reduction in activity%3B when associated with A-270 and A-271. Q->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8816484;Dbxref=PMID:8816484	
Q06547	UniProtKB	Mutagenesis	297	299	.	.	.	Note=Strongly reduces interaction with HCFC1 and transcriptional activation. Loss of activity%3B when associated with A-264 and A-265%2C or A-273 and A-275. IIV->AAA;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10675337,ECO:0000269|PubMed:8816484;Dbxref=PMID:10675337,PMID:8816484	
Q06547	UniProtKB	Mutagenesis	305	306	.	.	.	Note=Minor reduction in transcriptional activation. Moderate reduction in activity%3B when associated with A-270 and A-271. QQ->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8816484;Dbxref=PMID:8816484	
Q06547	UniProtKB	Mutagenesis	307	310	.	.	.	Note=Moderately reduces interaction with HCFC1 and transcriptional activation. Loss of activity%3B when associated with A-273 and A-275. VLTV->ALTA;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10675337,ECO:0000269|PubMed:8816484;Dbxref=PMID:10675337,PMID:8816484	
Q06547	UniProtKB	Sequence conflict	76	76	.	.	.	Note=H->L;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q06547	UniProtKB	Sequence conflict	246	246	.	.	.	Note=Missing;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q06547	UniProtKB	Sequence conflict	274	274	.	.	.	Note=T->A;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q06547	UniProtKB	Sequence conflict	341	341	.	.	.	Note=S->C;Ontology_term=ECO:0000305;evidence=ECO:0000305